Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Enrique Najar"'
Autor:
Luz M Moyano, Silvia M Montano, Percy Vilchez Barreto, Narcisa Reto, Luis Larrauri, Nicanor Mori, Mario Cornejo-Olivas, Erik Guevara-Silva, Fernando Urizar, Enrique Najar, Ricardo Gamboa, Cintya Azabache, Raquel Herrer Ticse, Lucia Bolivar-Herrada, Alex Doud, Peggy Martinez, J Jaime Miranda, Joseph R Zunt, Hector H García, Cysticercosis Working Group for Peru
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0254440 (2021)
Background and purposeStroke is the leading cause of neurological impairment in the South American Andean region. However, the epidemiology of stroke in the region has been poorly characterized.MethodsWe conducted a staged three-phase population-base
Externí odkaz:
https://doaj.org/article/e0a5593d233940e799829a3b7dddd159
Autor:
Herbert Saavedra, E. Javier Pretell, Hector H. Garcia, Hugo Umeres, Isidro Gonzales, Martin Gavidia, Enrique Najar, Lourdes Rodriguez, Javier A. Bustos
We thank Aba Mahamat and colleagues for their comments on our Article1 and patient data illustrating a difficult case successfully treated with combined albendazole and praziquantel. We do not deem use of the combination a “shift”, rather a refin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ab08b7d936694a0ceaaecbcfa171a0
https://hdl.handle.net/20.500.12866/5556
https://hdl.handle.net/20.500.12866/5556
Autor:
Herbert Saavedra, Martin Gavidia, E. Javier Pretell, Andres G. Lescano, Javier A. Bustos, Diego Escalante, Mirko Zimic, Lourdes Rodriguez, Hugo Umeres, Isidro Gonzales, Enrique Najar, Hector H. Garcia
Summary Background Neurocysticercosis causes a substantial burden of seizure disorders worldwide. Treatment with either praziquantel or albendazole has suboptimum efficacy. We aimed to establish whether combination of these drugs would increase cysti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe4f1a3f8510e63d90aae4d8c870602
https://europepmc.org/articles/PMC4157934/
https://europepmc.org/articles/PMC4157934/
Autor:
Alejandro Llanos-Cuentas, Iracema Arevalo, Greg Matlashewski, Richard A. Miller, Brian J. Ward, Tze-Chiang Meng, Eugenia Alvarez, Enrique Najar
Publikováno v:
Clinical Infectious Diseases. 33:1847-1851
Treatment failures for leishmaniasis with pentavalent antimonials, including meglumine antimonate, are increasingly common in many endemic areas. Imiquimod (Aldara; 3M Pharmaceuticals) is a novel immune response-activating compound, approved by the U
Publikováno v:
Revista Medica Herediana; Vol 27 No 1 (2016): Enero-Marzo; 46
Revista Medica Herediana; Vol. 27 Núm. 1 (2016): Enero-Marzo; 46
Revistas-Universidad Peruana Cayetano Heredia
Universidad Peruana Cayetano Heredia
instacron:UPCH
Revista Medica Herediana; Vol. 27 Núm. 1 (2016): Enero-Marzo; 46
Revistas-Universidad Peruana Cayetano Heredia
Universidad Peruana Cayetano Heredia
instacron:UPCH
Se reporta el caso de una mujer joven de 38 años de edad, con accidente cerebrovascular isquémico agudo y deficiencia de proteína S más foramen oval patente. La paciente acudió al servicio de emergencia por presentar hemiparesia derecha y disart